Deutsche Bank Ag\ Pro Qr Therapeutics N.V. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 108,762 shares of PRQR stock, worth $290,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,762

Previous 385,149 71.76%

Holding current value

$290,394

Previous $639,000 69.17%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.64 - $2.24 $453,274 - $619,106	-276,387 Reduced 71.76%	108,762 $197,000
Q1 2024 May 15, 2024	SELL	$1.89 - $2.85 $111 - $168	-59 Reduced 0.02%	385,149 $881,000
Q4 2023 Feb 14, 2024	BUY	$1.15 - $2.21 $442,989 - $851,309	385,208 New	385,208 $762,000
Q1 2022 May 13, 2022	SELL	$0.9 - $8.39 $109,269 - $1.02 Million	-121,410 Reduced 23.96%	385,208 $349,000
Q4 2021 Feb 11, 2022	SELL	$6.58 - $8.44 $488,130 - $626,112	-74,184 Reduced 12.77%	506,618 $4.06 Million
Q3 2021 Nov 04, 2021	SELL	$5.16 - $8.47 $3,596 - $5,903	-697 Reduced 0.12%	580,802 $4.86 Million
Q2 2021 Aug 11, 2021	SELL	$5.75 - $7.59 $709,440 - $936,461	-123,381 Reduced 17.5%	581,499 $3.92 Million
Q1 2021 May 13, 2021	BUY	$4.14 - $9.22 $2.17 Million - $4.83 Million	523,953 Added 289.59%	704,880 $4.66 Million
Q4 2020 Feb 16, 2021	BUY	$3.58 - $4.85 $647,718 - $877,495	180,927 New	180,927 $760,000
Q1 2020 May 14, 2020	SELL	$5.25 - $9.9 $19,136 - $36,085	-3,645 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.84 - $10.51 $200,533 - $360,892	-34,338 Reduced 90.4%	3,645 $36,000
Q3 2019 Nov 14, 2019	BUY	$5.76 - $9.44 $116,743 - $191,329	20,268 Added 114.41%	37,983 $217,000
Q2 2019 Aug 14, 2019	SELL	$9.1 - $15.55 $32,268 - $55,140	-3,546 Reduced 16.68%	17,715 $159,000
Q1 2019 May 15, 2019	BUY	$12.5 - $18.48 $156,100 - $230,778	12,488 Added 142.35%	21,261 $293,000
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $133,788 - $196,515	8,773 New	8,773 $137,000
Q4 2017 Feb 14, 2018	SELL	$2.8 - $4.8 $26,600 - $45,600	-9,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.35 - $6.45 $41,325 - $61,275	9,500	9,500 $46,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account